List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #52,781 to #52,830.
- The Heart in Polymyositis and Dermatomyositis → The heart in polymyositis and dermatomyositis
- The Heart in Primary Myocardial Tumors → The heart in primary myocardial tumors
- The Heart in Progressive Systemic Sclerosis (Scleroderma) → The heart in progressive systemic sclerosis (scleroderma)
- The Heart in Psoriasis → The heart in psoriasis
- The Heart in Reiter's Syndrome → The heart in Reiter's syndrome
- The Heart in Rheumatic Fever → The heart in rheumatic fever
- The Heart in Rheumatoid Arthritis → The heart in rheumatoid arthritis
- The Heart in Sarcoidosis → The heart in sarcoidosis
- The Heart in Sjögren’s Syndrome → The heart in Sjögren’s syndrome
- The Heart in Skin Cancers → The heart in skin cancers
- The Heart in Systemic Lupus Erythematosus (SLE) → The heart in systemic lupus erythematosus (SLE)
- The Heart in Takayasu Arteritis → The heart in takayasu arteritis
- The Heart in Temporal Arteritis / Giant Cell Arteritis → The heart in temporal arteritis / giant cell arteritis
- The Heart in The Heart in Head and Neck Tumors → The heart in head and neck tumors
- The Heart in Thyroid and Parathyroid Cancers → The heart in thyroid and parathyroid cancers
- The Heart in Tumors that Originated from Vascular Structure → The heart in tumors that originated from vascular structure
- The Heart in Ulcerative colitis → The heart in inflammatory bowel disease
- The Heart in Urinary System Tumors → The heart in urinary system tumors
- The Heart in Wegener's Granulomatosis → The heart in Wegener's granulomatosis
- The Heart in Wilson's Disease → The heart in Wilson's disease
- The Helsinki Heart Study → Helsinki heart study
- The IMPROVE risk score → IMPROVE score
- The IMPROVE score → IMPROVE score
- The Left Heart Catheterization → The left heart catheterization
- The Lesion Project → Pathophysiology of multiple sclerosis
- The Lipodystrophies and Other Rare Disorders of Adipose Tissue → Lipodystrophy
- The Living Guidelines → The living guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Aldosterone Blockers Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blockers Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS II Guidelines → The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Blood Pressure Control View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Diabetes Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Smoking Cessation View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Weight Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS III Guidelines → Atrial fibrillation cardioversion
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS I Guidelines → Atrial fibrillation cardioversion